Ophthalmology Times Supplement on Multimodal Imaging of Geographic Atrophy Available
Read here the proceedings from a symposium held during EURETINA 2016 with Professor Giovanni Staurenghi, Professor Steffen Schmitz-Valckenberg and Professor SriniVas Sadda recently published by Ophthalmology Times.
Multimodal imaging is essential to build up a full picture when assessing GA, as different techniques contribute different information. With treatments for GA in the pipeline, monitoring its development will become ever more important.
With an aging population, GA is going to become too common to be the exclusive preserve of retinal specialists and will have to be diagnosed, monitored, and possibly even treated by general ophthalmologists.
Every ophthalmologist will need to become familiar with the pathophysiology of GA and recognize its different phenotypes, distinguishing fast-progressing GA from more-indolent disease. Once treatment for GA becomes available, a growing number of general ophthalmologists will probably find it necessary to start performing intravitreal injections.
SPECTRALIS BluePeak Module
BluePeak is a non-invasive, scanning laser fundus imaging modality that provides a map of the retina which can reveal metabolic malfunction of diagnostic significance in many conditions such as AMD.